A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. - sprookjes - yvandenbroek - TriplyDB

A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.

A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.

http://www.wikidata.org/entity/Q37614180

about

Changes in skeletal collagen cross-links and matrix hydration in high- and low-turnover chronic kidney disease.Cortical bone mechanical properties are altered in an animal model of progressive chronic kidney disease.The use of fibroblast growth factor 23 testing in patients with kidney disease.Pathogenesis of arrhythmias in a model of CKD.Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy.A review of the effect of diet on cardiovascular calcification.Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease.Moderate chronic kidney disease impairs bone quality in C57Bl/6J mice Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease Subcutaneous nerve activity and mechanisms of sudden death in a rat model of chronic kidney disease.Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.Calcium supplementation in chronic kidney disease.Pharmacology of Bisphosphonates in Patients with Chronic Kidney Disease.What Animal Models Have Taught Us About the Safety and Efficacy of Bisphosphonates in Chronic Kidney Disease.Calcium as a cardiovascular toxin in CKD-MBD.Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis.Calcium Homeostasis in Health and in Kidney Disease.Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model.Citrate attenuates vascular calcification in chronic renal failure rats.Phosphate binders prevent phosphate-induced cellular senescence of vascular smooth muscle cells and vascular calcification in a modified, adenine-based uremic rat model.Skeletal vascular perfusion is altered in chronic kidney disease.

P2860

Q30873913-89F20E37-81AB-42F1-98B1-D763258C7DB2 Q33727902-14443870-CAE5-4E87-B3C3-5F335F4D1B7F Q33835743-2C195E13-0A82-4D0C-9B22-8E996E1CC3F2 Q34568828-A0137A36-A88E-49A7-BB68-FF1EAC6673EE Q35096719-B1AE69DD-047A-40BB-9182-D524F314BCF2 Q35585755-5FF12B15-EE16-4742-A312-65C854C89E18 Q35661168-BD2E26A5-CEF8-4D3A-8CB5-5426BA7836A3 Q36666085-9B88C3D7-6394-4383-8112-2224838F5D97 Q36803790-CD664474-C022-42AD-8B4B-424B31AC2076 Q36823369-E1A78158-ED4A-4010-AA3E-AEF1FFA5CD05 Q36854096-C16B563E-9FE1-430D-8EBF-833897D9CBAC Q37522423-3B4C7F23-6CFA-4C47-B1C5-35DE36656173 Q38240989-E343AE13-43B0-4204-8AB3-CB14C838F568 Q38458773-0BAC19D5-645C-4584-AAA2-98A4F98DDDAF Q38825566-D8A7410C-0E21-41A9-978F-AF1C2533B11D Q38941532-8FB4076D-C4A6-4A8A-B131-B293E83614FB Q43475954-ED19B081-9E3D-4706-B183-9ECD156325A5 Q48038085-B3D9E2C9-9D73-4B9A-AF7A-1E5583ADCE00 Q48045737-C141C90F-195D-4B62-A128-3FBF1FC03A04 Q51090162-D950E46D-1FF0-4963-894F-CB32917D273B Q53667873-8597418E-22F9-44B7-92C6-7498CCD09508 Q55378110-88B18101-657A-465E-B1AA-2A04A88A842A

P2860

A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD.

http://www.wikidata.org/entity/Q37614180

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A comparison of calcium to zol ...... one in an animal model of CKD.

@en

A comparison of calcium to zol ...... one in an animal model of CKD.

@nl

type

label

A comparison of calcium to zol ...... one in an animal model of CKD.

@en

A comparison of calcium to zol ...... one in an animal model of CKD.

@nl

prefLabel

A comparison of calcium to zol ...... one in an animal model of CKD.

@en

A comparison of calcium to zol ...... one in an animal model of CKD.

@nl

P1433

Q37614180-EE93C259-EB06-47FE-B26B-4A56E0898CC7

P1476

Q37614180-D77684AE-9E5D-4436-9EFE-94BCB6AF31D5

P2093

Q37614180-0DDF4438-2844-4E3E-B250-4EAAD3FF12E4

Q37614180-154B741F-4731-4BD2-8F90-9B4570933DC2

Q37614180-4AF5C3A8-6F90-4925-BBDD-9F81D0367BDE

Q37614180-766BC8F1-B9E9-4BB0-B607-B5FD652CEBA9

Q37614180-84E8219A-4290-4266-82A0-750E848CB156

Q37614180-FFE21F47-6C52-431E-822B-39CE97A6DA65

P2860

Q37614180-07756915-5371-40A8-BE67-C7CB66523EF3

Q37614180-17D13A09-936F-43B0-9A16-FCFDE9C251D8

Q37614180-1A63703E-4D02-48E3-8166-593F47D18B06

Q37614180-1AA31A98-7C5E-417D-886C-3D93747AA781

Q37614180-2219E98E-43E3-4736-9D35-6E439200FF17

Q37614180-27D6FF88-14E0-4B52-AD32-7FC98ED960F8

Q37614180-2B2AAE27-6B94-4106-A68A-CAF4BEF32BDE

Q37614180-3559E69D-A4E8-48EA-8712-DFE3200E610F

Q37614180-35D0345E-74A3-48C0-9734-7F3675430000

Q37614180-417E2E37-9A0C-43D6-A662-AE4303233A30

P304

Q37614180-8C532F9B-93BA-4DE5-BA5C-216E6DD16739

P31

Q37614180-6D412367-ED4C-4950-9F9A-0BB34345637A

P356

Q37614180-5E113750-EE51-4F56-BF76-64E54EA74BF7

P407

Q37614180-D42A33FE-BB15-490B-B085-364DB61788D4

P433

Q37614180-EA2517EE-F11D-4785-BD40-EEF26BAC2EB6

P478

Q37614180-2A8DA17F-2C5B-4D68-B58F-7D9C2BB12E9D

P50

Q37614180-ED8541F8-65B6-488C-8435-9428306E6FEB

P577

Q37614180-B34B9CC9-4B70-4483-A31E-102142A0DB33

P698

Q37614180-0401728D-2DAD-4249-8BE3-BF48A2D48C6A

P921

Q37614180-0DE32597-E290-4098-87AD-17D8CBF3B78D

Q37614180-2EDB541D-5C98-4DB2-B2D9-FBF299353B66

Q37614180-5F8FF24D-B0A5-4BBD-8AD2-668EDFEC804F

P932

Q37614180-308F9F6F-15CC-4787-B822-A4D2393C9431

P356

P1433

Journal of Bone and Mineral Research

P1476

A comparison of calcium to zol ...... bone in an animal model of CKD

@en

P2093

Christopher L Newman

http://www.w3.org/2001/XMLSchema#string

Matthew R Allen

http://www.w3.org/2001/XMLSchema#string

Neal X Chen

http://www.w3.org/2001/XMLSchema#string

Sharon M Moe

http://www.w3.org/2001/XMLSchema#string

Vincent H Gattone

http://www.w3.org/2001/XMLSchema#string

Xianming Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.

Osteoporosis in end-state renal disease.

Skeletal effects of zoledronic acid in an animal model of chronic kidney disease

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

FGF23 induces left ventricular hypertrophy

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.

P304

902-910

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBMR.2089

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24038306

http://www.w3.org/2001/XMLSchema#string

P921

zoledronic acid

vascular calcification

P932

3940692

http://www.w3.org/2001/XMLSchema#string